18 /100
LOW RISK
Score updated Apr 13, 2026

GRCE

Grace Therapeutics, Inc. — Stock Dilution Tracker

Track GRCE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track GRCE — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GRCE.
🔔 Track GRCE — Get forecast alerts →
💹 Market Data
Market Cap$54.47M
Shares Outstanding14.13M
Float9.77M
Cash$18.67M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 47.4% shares (2025Q4 vs prior)
22 institutional holders · 5.46M shares
#1 ADAR1 Capital Management, LLC 1.28M shares
#2 Nantahala Capital Management, LLC 1.18M shares
#3 BANK OF AMERICA CORP /DE/ 989.4K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.65M
Days to Cover3.3
% of Float16.9%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Mar 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
Track GRCE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GRCE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required